NORTHFIELD, Ill. – Medline plans to acquire a significant portion of the Hudson RCI brand of respiratory products from Teleflex, in a bid to strengthen its offerings in light of the COVID-19 pandemic.
Hudson RCI’s oxygen and aerosol therapy, active humidification and pulmonary hygiene products will complement Medline’s respiratory portfolio; will add two manufacturing facilities in Arlington Heights, Ill., and Nuevo Laredo, Mexico; and will add 1,000 employees.
“Hudson RCI is a natural addition to Medline,” said Andy Mills, president. “Medline has a long history of investing in key market areas to deliver new opportunities and efficiencies to health care providers. The acquisition brings one of the most admired respiratory brands into our world-class portfolio of products.”
The Hudson RCI corporate and manufacturing teams will become part of Medline’s Respiratory Division, reporting to Division President Tim Finnigan through Division Vice President Donna Mosakowski. In the United States, more than 30 sales specialists and clinical specialists will join the Acute Care Specialty Sales Group, reporting to Patrick Griffin, vice president of national field sales.
The acquisition also extends Medline’s European offerings and opens additional opportunities for development and support of customers in Europe.
The deal is expected to close later this year, pending regulatory reviews.
The M&A market for healthcare companies continues to strengthen in 2021 and ahead of the projected increases in US capital gains taxes. There is unprecedented capital in market, the lowest interest rates in US history and strong acquirer motivations for high quality healthcare companies. Across the continuum of care, buyers and investors are looking for well established, profitable businesses and offering strong valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
www.paragonventures.com
800-719-1555
